A Study to Investigate AG-236 in Subjects ≥18 Years of Age With Polycythemia Vera
Study sponsor: Agios Pharmaceuticals, Inc. · AGIO
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2030-08Estimated
Enrollment · participants245Estimated
Source updated2026-10-13Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.